Infusion of small amounts of plasma (1-2%) into isolated hearts perfused with Tyrode's solution causes vasoconstriction and augments regulation of coronary flow in response to changes in perfusion pressure (autoregulation). When plasma infusion is stopped, the vasoconstrictor effect dissipates within 5 minutes, whereas the autoregnlatory response remains for about 15 minutes. Thus the plasma-augmented autoregubtory response is not dependent on plasma-Induced vasoconstriction. Indomethadn (10 ftg/ml), an inhibitor of prostaglandin synthetase, causes coronary vasodflation and also abolishes the lingering autoregulatory response. These effects of indomethacin are counteracted by the addition of 1.5% plasma to the perfusate. Purification procedures led to the extraction of an active material from plasma which migrates as a single substance in thin layer chromatograms. This substance causes coronary vasoconstriction, augments autoregulation, and counteracts the effects of indometbacin in isolated rabbit hearts as effectively as plasma. The purified vasoactive substance stimulates a 2-fold increase in cardiac microsomal prostaglandin synthesis and a 5-fold increase using renal microsomal preparations. This substance counteracts indomethadn-induced inhibition of prostaglandin synthesis in microsomal preparations. These results provide convincing evidence that the effects of this pbtma constituent on the coronary vasculature are mediated by stimulation of prostaglandin synthesis. Thus it appears that prostaglandin synthesis plays an integral role In both the maintenance of coronary vascular tone and the autoregulatory response in isolated rabbit hearts.
INFUSION OF small amounts of blood plasma into isolated perfused rabbit hearts stimulates prostaglandin synthesis and produces a concomitant coronary vasoconstriction. 1 Furthermore, regulation of coronary flow in response to changes in perfusion pressure (autoregulation) is markedly improved by the addition of plasma (1-2%) to the perfusate. Prostaglandin synthesis is inhibited in these preparations by the prostaglandin synthetase inhibitors, indomethacin or 5,8,11,14-eicosatetraynoic acid, but the effect of these inhibitors is attenuated or abolished by plasma in a dose-dependent manner. Thus a relationship between cardiac prostaglandin synthesis, coronary vasoconstriction, and autoregulation of coronary flow exists. ' Evidence from experiments with isolated arterial strips 2 " 6 supports the concept of a relationship between maintenance of coronary vascular tone and endogenous prostaglandin or thromboxane synthesis, but the role of plasma in this relationship has not been elucidated. The relationship between cardiac prostaglandin synthesis and regulation of coronary flow in response to vasoactive chemicals, 6 -7 hypoxia, 8 '" and temporary occlusion'" 1 " has been examined, but the role of neither prostaglandins nor plasma in the cardiac autoregulatory response is understood. Plasma could improve the autoregulatory response indirectly, through its effects on vascular tone or prostaglandin synthesis. On the other hand, plasma could independently affect vasoconstriction, autoregulation, and prostaglandin synthesis. All of these effects could be caused by a single substance in plasma, or different plasma constituents could act independently.
With these possibilities in mind, we conducted experiments aimed at three goals: (1) separation of the effects of plasma on vasoconstriction from those on autoregulation, (2) purification of the vasoactive substance or substances in plasma and (3) examination of the direct effects of the vasoactive material extracted from plasma on prostaglandin synthesis in microsomal preparations.
Methods

Isolated Heart Preparations
Except for the method of measuring coronary flow, hearts isolated from New Zealand male rabbits (2.5-3.5 kg) were perfused as described previously. 1 Briefly, left ventricular pressure was measured through an isovolumic balloon catheter inserted in the left ventricle. Perfusion pressure and perfusate temperature were monitored with sensors in the perfusion manifold. Arterial and venous oxygen tensions were measured with flow-through oxygen probes. Coronary flow was measured gravimetrically from a drain inserted into the right ventricle. The effluent was collected in a 10-mJ automatic siphon which was suspended from a strain gauge. The amplified signal from the gauge produced a saw-toothed pattern on the record- VOL. 42, No. 3, MARCH 1978 ing chart. The slope of the line produced as the siphon filled was proportional to the coronary flow rate. Changes in flow caused instantaneous changes in the slope. Signals from all sensors were amplified and recorded on a multichannel recorder.
The hearts were perfused at 37°C with Tyrode's solution or with 1.5% rabbit plasma in Tyrode's solution. Left ventricular pressure and oxygen uptake were continuously monitored. Experiments were conducted only while these values remained constant. Perfusion pressure was maintained by regulating the pressure of the gas mixture in the perfusate reservoir.
Bioassay of Vasoactive Material
The vasoconstrictor effect of plasma was used as the basis for a bioassay in hearts perfused with Tyrode's solution (60 mm Hg). Plasma was infused at different rates to determine the standard response. Test samples which were reconstituted with Tyrode's solution were infused at different rates for comparison.
Fractionation and Extraction Procedures
Substances that were bound to plasma proteins were removed with activated charcoal, as described by Chen, 11 except that a pH of 6.0 was used. Substances to be complexed with charcoal-treated (inactivated) albumin were dried in vacuo. They were then mixed with inactivated albumin dissolved in Tyrode's solution (5 mg/ml) for 1 hour. In some experiments, the extracts were first adsorbed onto diatomaceous earth (Celite) before addition of the albumin solution to facilitate transfer of nonpolar lipids to the albumin."
Chemicals
Tritium-labeled arachidonic acid (5, 6, 8, 9, 11, 12, 14, H), 64 Ci/mmol (New England Nuclear), was added to unlabeled arachidonic acid (Sigma) and diluted with hexane. The hexane was evaporated with nitrogen before the introduction of aqueous media. Indomethacin (Sigma) was dissolved in 95% ethanol (10 mg/ml) just before use. Ethanol in concentrations up to 10 times greater than that required for the introduction of indomethacin had no effect on coronary flow in the isolated heart or prostaglandin synthesis in the microsomal preparations.
Microsomal Preparations and Assay of Radiolabeled Prostaglandins
Microsomal fractions were prepared 14 from the ventricle and auricle of the heart and renal medullary tissues immediately following their excision from male New Zealand rabbits. The microsomal pellets (100,000 g, 1 hour) were suspended in 50 ITIM Tris buffer (pH 8.5). Portions of the suspensions were incubated for 4 minutes in test tubes in a shaking water bath at 37 C C. The incubation medium (0.5-ml final volume) contained glutathione (0.8 ITIM) epinephrine (1 min), 3 H-arachidonate (6 x 10" 3 mM, 2 x 10 s counts/min), and 50 mM Tris buffer (pH 8.5). In agreement with the work of others using microsomal preparations of both cardiac 14 and renal 15 tissues, preliminary experiments showed that these concentrations of glutathione and epinephrine produced maximal effects.
The purified vasoactive material was dried with nitrogen, then dissolved in the incubation medium. Incubations were started by the addition of the microsomal suspension (1.0-1.5 mg protein). Incubations were stopped by reducing the pH to 2.5 with 5 N HO followed by addition of 1.0 ml of cold (0°C) ethyl acetate. In tests using these conditions, no significant conversion of PGE 2 to PGA 2 occurred. Zero time controls, to which the 5 N HO was added before the microsomal suspension, were used in each experiment. These controls produced the same level and distribution of background radioactivity on thin layer plates as controls incubated with boiled microsomes.
The labeled prostaglandins were extracted with ethyl acetate and separated by thin layer chromatography as described previously. 1 The regions containing prostaglandins and similar regions obtained from the control incubations were scraped from the thin layer plates into liquid scintillation counting vials to determine their radioactivity.
Thin Layer Chromatography
Silica gel thin layer plates (LQ, Quantum Industries) were used with the following solvent systems: diethyl ether-hexane-acetic acid (70:20:1) for separation of lipids; chloroform-methanol-acetic acid-water (60:30:8:3) or chloroform-methanol-ammonia (60:30:4) for phospholipids; and ethyl acetate-benzene-acetic acid (24:12:1) for prostaglandins. Phospholipids were located by spraying the plates with ammonium molybdate. 16 Other lipids were detected with iodine vapor. The presence of amines was detected by spraying the plates with ninhydrin reagent. 17 The identity of the labeled prostaglandins was substantiated in the following ways: (1) examination of the radiolabeled substances using a second solvent system [benzene-dioxane-acetic acid (20:20:1)]," 1 (2) comparing the migration of methyl esters of the recovered radiolabeled substances to the migration of methyl esters prepared from authentic prostaglandins, 18 (3) conversion of prostaglandin Ej prostaglandin B 2 , 19 followed by chromatographic analysis using the ethyl acetate-benzeneacetic acid (24:12:1) solvent system.
Results
Although vasoconstriction induced by plasma occurs rapidly, about 5 minutes are required to dissipate this effect after cessation of plasma infusion. 1 If the time required for loss of the plasma-augmented autoregulatory response were markedly different from this, then the one could not be an indirect consequence of the other. To evaluate the autoregulatory response, the perfusion pressure was abruptly changed from 60 mm Hg to 40, 80, or 100 mm Hg, and the changes in coronary flow were observed. During perfusion with 1.5% plasma, abrupt changes in pressure caused passive, homodirectional changes in flow, followed by a return towards the original flow rate (Fig. 1 ). The return toward the original flow rate was used as a measure of the autoregulatory response. In experiments reported previously, 1 this response was negligible 30 minutes after perfusion with 2% plasma. When evaluated at shorter intervals, the autoregulatory response was found to remain after the vasoconstrictor effect of plasma had been lost ( Fig. 2 and Fig. 3 , A and B). Five minutes after perfusion with 1.5% plasma, when the vasoconstrictor effect had dissipated, autoregulatory responses were as effective as in the presence of plasma. After 15 minutes without plasma, the responses, though diminished, were still evident. Thus the effect of plasma on autoregulation was lost more slowly than its effect on vascular tone.
Since the autoregulatory response persisted after cessation of plasma perfusion, the effect of inhibition of prostaglandin synthesis on autoregulation could be examined without the complications arising from the presence of plasma in the perfusate. Hearts were perfused with 1.5% plasma and their autoregulatory responses determined. The perfusate was then changes to Tyrode's solution as indomethacin infusion was started. The infusion rate for indomethacin was adjusted to maintain a concentration of 10 pig/ml in the coronary perfusate. After 5 minutes, the autoregulatory response was determined. The perfusate was then switched to 1.5% plasma, while indomethacin infusion (10 jxg/ml) was maintained and the autoregulatory response determined in the presence of both plasma and indomethacin.
While the hearts were being perfused with Tyrode's solution, indomethacin abolished the autoregulatory response ( Fig. 3C ). As previously reported, 1 indomethacin also caused an increase in the basal flow rate. Addition of plasma during indomethacin infusion reduced the basal flow rate and partially restored the autoregulatory response ( Fig. 3D ).
The autoregulatory response to an increase in pressure was an increase in coronary resistance, whereas the converse occurred when the pressure was decreased. To evaluate further the effect of indomethacin on responses involving decreases in pressure, the magnitude of the change in coronary resistance produced when the perfusion pressure was abruptly lowered from 100 to 60 mm Hg was compared to that produced by increasing the pressure from 60 to 100 mm Hg (Table 1) . Indomethacin inhibited both vasoconstriction and vasodilation in response to changes in perfusion pressure, and plasma counteracted the effect of indomethacin in both cases. Results are expressed as mean ± SE. Data were obtained from six hearts. Each heart was tested with the perfusates in the following order: 1.5% plasma, Tyrode's solution, Tyrode's solution + indomethacin (10 g/ml), 1 5% plasma + indomethacin (10 ^ig/ml). Tests in the absence of plasma were conducted 5 minutes after cessation of plasma perfusion At a concentration of 10/xg/ml, indomethacin abolishes the release of prostaglandin-like activity in these preparations in the absence of plasma but not in its presence. 1 Hence, these results suggest that autoregulation might be augmented through the effect of plasma on prostaglandin synthesis. This possibility could be evaluated by examining the direct effects of plasma on microsomal prostaglandin synthetase. Since plasma contains substances such as aromatic amines and hemoglobin which might affect prostaglandin synthesis, 20 these experiments were deferred until a purified vasoactive substance was obtained.
Purification of the Vasoactive Material
The vasoconstrictor effect of plasma was used as the basis for a bioassay. The coronary vasoconstrictions produced by various plasma fractions and extracts were compared to those produced by standard doses of plasma.
When plasma was passed through an ultrafilter (Amicon UM-10) which retains molecules with a molecular weight greater than 10,000, all the activity was retained by the filter. When the plasma proteins were precipitated in three fractions with ammonium sulfate (0-33%, 34-50%, 51-95% saturation), more than 80% of the activity was found in the albumin fraction (51-95% saturation) ( Table  2 ). Since a variety of substances are bound to albumin, 21 albumin or plasma was treated with activated charcoal, which removes bound lipids and other substances. 12 All of the activity was removed by this treatment (Table 3 ). This indicates that the activity is due to a lipid or other substance which normally is bound to albumin. Activity was determined on at least three preparations of each material.
All extracts were complexed with inactivated albumin for testing. Values represent range of activity. See text for details of the bioassay
To remove the lipid-soluble substances for testing, samples of plasma or albumin were extracted with chloroforrn-methanol (2:1). It has been demonstrated that some fatty^ acids depress contractility and coronary flow in isolated rabbit hearts unless they are first bound to albumin. 22 Since these fatty acids would be present in the chloroform-methanol extract and could cause nonspecific depression of coronary flow, the extracts were first complexed 13 with charcoal-treated, inactivated albumin for testing. Indeed, when the chloroform-methanol extract was administered to isolated hearts in the absence of albumin (by drying the extract and dissolving the residue in bicarbonate buffer, pH 8.5, before diluting with Tyrode's solution), the hearts were depressed but in a manner unlike that produced by plasma. The vasoconstriction occurred more slowly but then became more pronounced. The vasoconstriction was accompanied by irregular contractions or ventricular fibrilation. Recovery took much longer, and coronary flow seldom returned to the previous level. When the chloroform-methanol extracts were combined with inactivated albumin for testing, the response of the hearts was similar to that produced by plasma. In subseqOent experiments, all extracts were complexed with inactivated albumin for testing (Table 3) .
To purify the active material further, plasma was first extracted with diethyl ether (pH 3.7) and then with 2:1 chloroform-methanol (pH 2.5). Thin layer chromatographic analysis indicated that most of the neutral lipids, fatty acids, and heme were located in the ether extract. The chloroform-methanol extract contained phospholipids and other polar compounds along with some neutral lipids. Activity was found in the chloroform-methanol extract but in neither the ether extract nor the aqueous phase (Table 3) .
When the lipids in the chloroform-methanol extract were separated by thin layer chromatography, activity was found in the region of the chromatogram containing phospholipids but not in the regions containing fatty acids, glycerides, or cholesterol esters. When the phospholipids were separated by thin layer chromatography, using the acidic solvent [chloroform-methanol-acetic acidwater (60:30:8:3)], all the activity was associated with the region containing sphingomyelin (Rf 0.35) (Fig. 4 ). When this active region was rechromatogrammed using chloroform-methanol-ammonia (30:15:2), the activity was found just above the origin (R f 0.1), well separated from sphingomyelin (R, 0.3-0.4). When the basic solvent was used before the acidic solvent, the activity migrated to the same respective levels in each solvent. In either solvent the activity was confined to a single band less than 1 cm wide. Since the vasoconstrictor effect was used as the basis for the bioassay, the effects of the purified material on indomethacin-induced vasodilation and on autoregulation were also examined. Infusion of indomethacin into hearts perfused with Tyrode's solution causes an increase in coronary flow which is counteracted by the addition of plasma to the perfusate.' The purified vasoactive material combined with inactivated albumin also counteracted the effect of indomethacin on coronary flow (Fig. 5 ). Addition of inactivated albumin, in the absence of the vasoactive material, did not counteract the vasodilation caused by indomethacin. When the purified substance was complexed with inactivated albumin and infused into isolated hearts, it restored the autoregulatory response which had been abolished by indomethacin. The autoregulatory response of hearts was measured by the change in coronary resistance caused by increasing the perfusion pressure from 60 to 100 mm Hg. In control tests using Tyrode's solution, the response was a 36% increase in resistance. With indomethacin (10 pig/ml) in the perfusate, resistance decreased by 6%. Addition of the purified vasoactive substance combined with inactivated albumin (in a concentration equivalent to 1 % plasma) restored the autoreg-ulatory response to a 40% increase in resistance. Addition of inactivated albumin (0.75 mg/ml) to the perfusate did not restore the autoregulatory response (resistance decreased by 11%). Thus the effects of plasma on vascular tone, autoregulation, and indomethacin-induced vasodilation are produced by the purified substance.
Effect of the Vasoactive Substance on Microsomal Prostaglandin Synthesis
To examine the action of the vasoactive material on microsomal prostaglandin synthesis, preparations from cardiac ventricle and auricle, as well as renal medulla, were incubated with 3 H-arachidonate. In these experiments, the vasoactive material was not combined with inactivated albumin but was dried with nitrogen and dissolved in the incubation medium. The principal prostaglandins recovered in these experiments were prostaglandins F 2a , Ei, and D 2 . The distribution of radioactivity on the chromatograms was similar to that reported by Blackwell et al. ls for microsomal preparations of rabbit kidney. In addition to peaks of radioactivity for the prostaglandins, there was a region of high radioactivity near the origin and another one located between the arachidonate standard and the prostaglandin A 2 standard. Different microsomal preparations of ventricular tissue varied considerably in their specific activity (Table 4 ). Limas and Conn 14 reported a 10-fold difference in specific activities for different microsomal preparations from canine ventricles. The vasoactive material caused a 2-fold increase in the rate of microsomal prostaglandin synthesis in preparations from cardiac tissues and a 5-fold increase in preparations of renal medulla ( Table 5 ). Eluents from adjacent (control) zones of the thin layer chromatography plates used in purifying the vasoconstrictor did not stimulate microsomal prostaglandin synthesis. Hence, the vasoconstrictor has a direct effect on prostaglandin synthesis.
Indomethacin inhibited prostaglandin synthesis in preparations from both cardiac and renal tissues. Because of the higher yield and specific activity of renal microsomal material, these preparations were routinely used to examine the relationships between the roles of the vasoactive substance and indomethacin in prostaglandin synthesis. Indomethacin (5 /xg/ml) inhibited prostaglandin synthesis by 90% in the absence of the vasoactive substance ( Table  6 ). Addition of the vasoactive substance in the presence of indomethacin (5 /xg/ml) stimulated prostaglandin synthesis above the control level. At 10 /Ag/ml, indomethacin ..•hibited prostaglandin synthesis by 97% in the absence of the vasoactive substance but by only 60% in its presence (Table 6 ). Hence, the vasoactive material counteracts the effects of indomethacin.
Discussion
These studies show that a material, which is bound to albumin in rabbit plasma and which migrates as a single substance on thin layer chromatograms, acts on both coronary vascular tone and autoregulation in isolated rabbit hearts. Since the effect on autoregulation lingers after the vasoconstrictor action has dissipated, the vasoactiye substance must affect each independently. HOW- One ml equivalent (ml eq) of vasoconstrictor is the amount extracted from 1 ml of plasma. Microsomal preparation of renal medulla (;i = 6). See text for additional details ever, we previously reported that, in addition to its vasoaction, plasma stimulated prostglandin synthesis and counteracts indomethacin-induced inhibition of prostaglandin synthesis in isolated rabbit hearts.' Herein we have shown that the purified vasoactive substance from plasma directly stimulated prostaglandin synthesis and counteracts the inhibition caused by indomethacin in microsomal preparations. This is convincing evidence that the physiological effects of plasma result from stimulation of cardiac prostaglandin synthesis. Hence prostaglandin synthesis appears to play an integral role in both cardiac autoregulation and maintenance of coronary vascular tone.
This does not imply that prostaglandins are the causative agents. Evidence suggests that indomethacin inhibits the conversion of arachidonic acid to prostaglandin Gi- 20 This labile endoperoxide serves as a precursor for prostaglandin H 2 , which is an intermediate in the synthesis of both prostaglandins and thromboxanes." Since the vasoactive material antagonizes indomethacin, it might be expected to stimulate the synthesis of prostaglandin H 2 as well as thromboxanes and prostaglandins. Thromboxanes have been shown to cause contraction of bovine and porcine coronary arterial strips, 2 -6 whereas prostaglandins are vasoactive in isolated rabbit hearts only when administered in extremely high doses.' Although evidence of thromboxane synthesis was not found in this study, thromboxanes could have been produced in amounts which were below the level of detection.* 4 Although species differences in response to prostaglandins exist, 5 stimulation of both prostaglandin and thromboxane synthesis by the vasoactive substance might reconcile our results with some of those of others. Several investigators 1 -6 -B -l0 - 25 have reported a relationship between cardiac prostaglandin synthesis and coronary vasodilation, whereas our results show that an increase in prostaglandin synthesis is accompanied by vasoconstriction. However, the vasoactive substance not only improved constrictor autoregulatory responses but also those which consisted of vasodilation (Table 1 ). Perhaps the degree of coronary constriction is dependent on the relative rates of synthesis of a vasoconstrictor such as a thromboxane or prostaglandin H, and a vasodilator pros-taglandin. The vasoactive substance could stimulate synthesis of both vasodilator and vasoconstrictor, causing a net vasoconstriction in isolated perfused hearts. Factors such as hypoxia, 8 -9 the action of bradykinin, 6 or decreases in perfusion pressure might lead to the synthesis of vasodilatory prostaglandins at the expense of vasoconstrictors, resulting in vasodilation.
The effects of the vasoactive substance are evident within seconds after infusion but require several minutes to dissipate. This indicates that the vasoactive substance rapidly enters cardiac tissues but is lost, through metabolism or diffusion, at a slower rate. Since the effect of this substance on autoregulation disappears more slowly than the effect on vascular tone, the vasoactive agent either dissipates at a slower rate from the autoregulatory elements or is effective at lower concentrations. Since low concentrations of plasma produce maximal effects, 1 neither vascular tone nor the autoregulatory response would be affected by fluctuations in blood levels of the vasoactive substance. Thus, this substance is essential for maintenance of coronary vascular tone and the autoregulatory response but does not act as a regulator.
In addition to providing evidence that the different effects of plasma are due to the same substance, the isolation procedures used indicate that the vasoactive substance is different from other substances that have been shown to stimulate prostaglandin synthesis. Hemoglobin, heme, aromatic amines, and fatty acid precursors of prostaglandin synthesis such as arachidonate are found in plasma and stimulate prostaglandin synthesis. 20 Phospholipids could interfere by providing arachidonate via the action of a phospholipase. However, the ether extract of plasma contained large amounts of heme and fatty acids but demonstrated no vasoactivity. The activity was separated chromatographically from fatty acids and all the phospholipids. It is conceivable that the vasoactive substance could be an amine, but evidence has been presented 10 which indicates that aromatic amines act on the conversion of G type prostaglandins to prostaglandins of the H type, whereas indomethacin inhibits the synthesis of G type prostaglandins. Since the vasoactive material antagonizes indomethacin, its action is probably unlike that of the aromatic amines. Furthermore, an aromatic amine, epinephrine, was present in the incubation medium at a concentration which produced maximum stimulation, but the vasoactive substance stimulated prostaglandin synthesis beyond this. Hence the vasoactive substance appears to be unlike substances that are known to stimulate prostaglandin synthesis.
